First Tracks Biotherapeutics Inc (B43) Stock Price & News

All values in USD	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	41.46M	39.27M	33.96M	25.64M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	9.82M	6.63M	18.86M	9.29M
Operating expense	51.28M	45.90M	52.81M	34.94M
Total operating expenses	51.28M	45.90M	52.81M	34.94M
Operating income	-51.28M	-45.90M	-52.81M	-34.94M
Other non operating income	-7.00K	-13.00K	-1.00K	-1.00K
EBT including unusual items	-47.20M	-42.44M	-50.48M	-33.37M
EBT excluding unusual items	-47.20M	-42.44M	-50.48M	-33.37M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-47.20M	-42.44M	-50.48M	-33.37M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-0.95
Interest and investment income	4.09M	3.47M	2.33M	1.56M
Interest expense	-	-	-	-
Net interest expenses	4.09M	3.47M	2.33M	1.56M
Depreciation and amortization charges	-	-	-	-
EBITDA	-51.13M	-45.76M	-52.69M	-34.83M
Gain or loss from assets sale	-	-	-	-

Finance